<DOC>
	<DOCNO>NCT00293631</DOCNO>
	<brief_summary>To determine whether single dose intravenous lornoxicam superior intravenous placebo management post-operative pain patient surgical removal bunion lower extremity . One-fourth patient study receive single dose intravenous ketorolac management pain one-fourth patient study receive single dose intravenous placebo .</brief_summary>
	<brief_title>Study Lornoxicam Ketorolac Placebo Post-Operative Pain After Bunionectomy</brief_title>
	<detailed_description />
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Lornoxicam</mesh_term>
	<mesh_term>Piroxicam</mesh_term>
	<criteria>Subjects schedule primary unilateral first metatarsal bunionectomy local anesthetic . Subjects contraindication surgery allergy study medication similar medication . Subjects generally good health uncontrolled chronic illness disease . Subjects pregnant . Subjects significant obesity . Subjects medically significant heart , liver , kidney , lung endocrine disease . Subjects active viral disease , i.e . hepatitis , HIV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>